Givlaari™ (givosiran) for the Treatment of Acute Hepatic Porphyria
The drug is available in 189mg / mL strength in a single-dose vial for subcutaneous administration. Credit: Business Wire.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more